Detalhe da pesquisa
1.
Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection.
J Viral Hepat
; 26(3): 362-372, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30450781
2.
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection.
Hepatology
; 68(4): 1298-1307, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29672891
3.
Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.
J Infect Dis
; 217(3): 474-482, 2018 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29228392
4.
Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28264852
5.
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy.
Int J Drug Policy
; 66: 73-79, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735896
6.
Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.
PLoS One
; 13(5): e0198296, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29851985
7.
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability.
J Med Chem
; 61(3): 1153-1163, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29342358
8.
Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial.
Lancet Gastroenterol Hepatol
; 2(7): 494-500, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28416221
9.
Drug-Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers.
Clin Pharmacokinet
; 55(8): 1003-14, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26895022
10.
A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteers.
Clin Pharmacol Drug Dev
; 3(4): 314-20, 2014 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27128838
11.
Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.
AAPS J
; 10(4): 537-51, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18989788